Blog
ISPE 2024: Exploring the impact of removing race as a diagnostic factor for chronic kidney disease: Time to potassium-lowering drugs
ISPE 2024: Real-world patterns in GLP-1 RA switching from 2018-2023 in the US
Truveta moves up on GeekWire’s Top 200 startup list
Advancing psoriasis research with regulatory-grade EHR data
How UnitedHealth turned a questionable artery-screening program into a gold mine
Exploring medication switching trends from Humira to approved biosimilars
Improving ovarian cancer outcomes with EHR data

